Caspase-9 is a protein in humans that is encoded by CASP9 gene. Involved in the activation cascade of caspases responsible for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to activation of the protease which then cleaves and activates caspase-3. Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-ribose) polymerase (PARP).
The following CASP9 reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
CASP9 Antibodies for Homo sapiens (Human)
|Code||Product Name||Species Reactivity||Application|
|CSB-PA000012||Human||WB, IHC, IF, ELISA|
|CSB-PA000686||Human,Mouse,Rat||WB, IHC, ELISA|
|CSB-PA001235||Human,Mouse,Rat||WB, IHC, IF, ELISA|
|CSB-PA001251||Human||WB, IHC, IF, ELISA|
|CSB-PA070004||Human||WB, IHC, ELISA|
|CSB-PA070005||Human||WB, IHC, ELISA|
|CSB-PA070006||Human||WB, IF, ELISA|
|CSB-PA070007||Human||WB, IHC, ELISA|
|CSB-PA070008||Human,Monkey||WB, IHC, IF, ELISA|
|CSB-RA004555A0HU||Human||ELISA, WB, IF, FC|
|CSB-PA004555LA01HU||Human, Mouse||ELISA, WB, IHC, IF|
CASP9 Proteins for Homo sapiens (Human)
In Vivo Biotinylation in E.coli
CASP9 ELISA Kit for Homo sapiens (Human)
|Code||Product Name||Sample Types||Sensitivity|
|CSB-E08862h||serum, plasma, tissue homogenates, cell lysates||0.195 ng/mL|
Caspase-9, encoded by the CASP9 gene, is one of the initiator caspases  that belong to cysteine protease family. Caspase-9 is expressed early in embryogenesis and ubiquitously in adult tissues. Human caspase-9 contains three major domains: a prodomain with a caspase recruitment domain (CARD), the large subunit catalytic domain (LSCD), and the small subunit catalytic domain (SSCD) . Both LSCD and SSCD are also called catalytic domain. Prodomain and catalytic domains are connected by the linker domain, which contains the sites of amino acid residues involved in the proteolytic processing and post-translational modifications of the procaspase-9 . All caspases are synthesized as inactive zymogens in cells and must undergo proteolytic cleavages to become fully activated. The activation of caspase-9 is complexed with apoptotic protease activating factor 1 (APAF-1) by their respective CARD domain . Yini Li et al. demonstrated that the APAF-1 apoptosome activates caspase-9 by either suppressing the inhibition mediated by the CARD domain or stimulating the catalytic activity of the protease domain . Active caspase-9 further stimulates downstream effector caspase and some Bcl2 family members, thus leading to apoptosis . The cleavage of procaspase-9 is blocked by ERK1/2, DYRK1A, CDK1-cylinB1, and p38α at the Thr125 phosphorylation site, which is a well-known inhibitory site of caspase-9. Mutation of Caspase- 9 results in embryonic lethality and defective brain development associated with decreased apoptosis .
 Boatright KM, Salvesen GS Mechanisms of caspase activation [J]. Curr Opin Cell Biol. 2003 Dec; 15(6):725-31.
 Yuan S, et al. Structure of an apoptosome-procaspase-9 CARD complex [J]. Structure, 2010, 18(5):571-583.
 Li P, Nijhawan D, et al. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade [J]. Cell. 1997; 91 (b): 479-489.
 Yini Li, Mengying Zhou, et al. Mechanistic insights into caspase-9 activation by the structure of the apoptosome holoenzyme [J]. PNAS February 14, 2017, 114 (7) 1542-1547.
 Cohen G.M Caspases the executioners of apoptosis [J]. Biochem. J. 1997; 326: 1-16.
 Clem R.J, Cheng E.H, et al. Modulation of cell death by Bcl-XL through caspase interaction [J]. Proc. Natl. Acad. Sci. USA. 1998; 95: 554-559.
 Razqallah Hakem, Anne Hakem, et al. Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo [J]. VOLUME 94, ISSUE 3, P339-352, AUGUST 07, 1998.